Reversal of Age-related Alterations in Synaptic Plasticity by Blockade of L-type Ca2+ Channels
Overview
Authors
Affiliations
The role of L-type Ca2+ channels in the induction of synaptic plasticity in hippocampal slices of aged (22-24 months) and young adult (4-6 months) male Fischer 344 rats was investigated. Prolonged 1 Hz stimulation (900 pulses) of Schaffer collaterals, which normally depresses CA3/CA1 synaptic strength in aged rat slices, failed to induce long-term depression (LTD) during bath application of the L-channel antagonist nifedipine (10 microM). When 5 Hz stimulation (900 pulses) was used to modify synaptic strength, nifedipine facilitated synaptic enhancement in slices from aged, but not young, adult rats. This enhancement was pathway-specific, reversible, and impaired by the NMDA receptor (NMDAR) antagonist DL-2-amino-5-phosphonopentanoic acid (AP5). Induction of long-term potentiation (LTP) in aged rats, using 100 Hz stimulation, occluded subsequent synaptic enhancement by 5 Hz stimulation, suggesting that nifedipine-facilitated enhancement shares mechanisms in common with conventional LTP. Facilitation of synaptic enhancement by nifedipine likely was attributable to a reduction ( approximately 30%) in the Ca2+-dependent K+-mediated afterhyperpolarization (AHP), because the K+ channel blocker apamin (1 microM) similarly reduced the AHP and promoted synaptic enhancement by 5 Hz stimulation. In contrast, apamin did not block LTD induction using 1 Hz stimulation, suggesting that, in aged rats, the AHP does not influence LTD and LTP induction in a similar way. The results indicate that, during aging, L-channels can (1) facilitate LTD induction during low rates of synaptic activity and (2) impair LTP induction during higher levels of synaptic activation via an increase in the Ca2+-dependent AHP.
McKiernan E, Herrera-Valdez M, Marrone D PLoS One. 2024; 19(9):e0308809.
PMID: 39231135 PMC: 11373847. DOI: 10.1371/journal.pone.0308809.
Neural ageing and synaptic plasticity: prioritizing brain health in healthy longevity.
Navakkode S, Kennedy B Front Aging Neurosci. 2024; 16:1428244.
PMID: 39161341 PMC: 11330810. DOI: 10.3389/fnagi.2024.1428244.
Mill N, Ogoe R, Valibeigi N, Chen D, Kimbal C, Yoon S Behav Pharmacol. 2024; 35(2-3):79-91.
PMID: 38451022 PMC: 10921984. DOI: 10.1097/FBP.0000000000000764.
Pham T, Hussein T, Calis D, Bischof H, Skrabak D, Cruz Santos M Cell Mol Life Sci. 2023; 80(12):369.
PMID: 37989805 PMC: 10663188. DOI: 10.1007/s00018-023-05016-y.
Rumian N, Freund R, DellAcqua M, Coultrap S, Bayer K Sci Signal. 2023; 16(795):eade5892.
PMID: 37490545 PMC: 10485821. DOI: 10.1126/scisignal.ade5892.